Innovative canadian helicobacter pylori screening initiative in community pharmacy (icanhelpic) study

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: PAPASTERGIOU, John (University of Toronto, Pharmacy, Toronto, Canada)
  • Co-author(s): John Papastergiou: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada;School of Pharmacy, University of Waterloo, Kitchener, Canada;, Shoppers Drug Mart, Toronto, Canada
    Wilson Li: Shoppers Drug Mart, Toronto, Canada
    Sadig Salim: Shoppers Drug Mart, Toronto, Canada
  • Abstract:

    Background

    H.pylori as identified by the WHO is a major risk factor of gastritis, peptic ulcer disease,and gastric carcinomas. As point of care screening technology becomes more widely available, pharmacists are ideally suited to utilize this tool to screen patients with H.pylori infection.

    Purpose

    The objective of this study is to evaluate the..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login